BIOTECH STOCKS
Glioblastoma Readout Could be Inflection Point for $DFFN Diffusion Pharmaceuticals
Diffusion Pharmaceuticals Inc. (DFFN) has a current market cap of $7.6 million, but on a fully diluted basis, it is $18.3 million after a stock offering was completed last week (the offering included $8 million […]